hydroxyl radical has been researched along with lazabemide in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (lazabemide) | Trials (lazabemide) | Recent Studies (post-2010) (lazabemide) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 114 | 11 | 28 |
| Protein | Taxonomy | hydroxyl radical (IC50) | lazabemide (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.03 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.077 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, N; Himori, N; Suzuki, T; Tanaka, Y; Ueno, K | 1 |
1 other study(ies) available for hydroxyl radical and lazabemide
| Article | Year |
|---|---|
MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Ischemia; Clorgyline; Dopamine; Hydroxyl Radical; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Picolinic Acids; Reperfusion | 1995 |